Skip to main content
HELE logo

Helen of Troy Limited (HELE) Stock Price & Analysis

Helen of Troy Limited (HELE) — MoonshotScore 59/100 (Fair band), calculated Nov 18, 2026. Price $34.44 (-1.85%), as of the Nov 20, 2026 trading session; market cap $806M.

Educational signal · not a buy or sell recommendation · How to read this

$34.44 −$0.65 (-1.85%) Market Cap $806M

Helen of Troy Limited · HELE · NASDAQ

Helen of Troy Limited is a global consumer products company operating through Home & Outdoor, Health & Wellness, and Beauty segments. The company offers a diverse portfolio of branded products sold through various retail channels and direct-to-consumer platforms.

Price as of Nov 20, 2026

Key Statistics

59 of 100

MoonshotScore v2 · Helen of Troy (HELE)

Fair
Business Quality Average (49)
Financial Safety Fragile (18)
Valuation Fair (61)
Growth Durability Flat (48)
Momentum Surging (97)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Strong price action running well ahead of the business — a fragile balance sheet underneath; a move to treat with suspicion, not chase. Business Quality: Average; Financial Safety: Fragile; Valuation: Fair; Growth Durability: Flat; Momentum: Surging.

  • EPS beat 1 of the last 4 reports
  • Altman Z 1.83 · Piotroski F 5
  • ROE -11.1% · ROA 2.8% · current ratio 1.65

Holding back: balance-sheet strain

Helping: positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for HELE (58 recorded, newest six shown)
RecordedScoreBand
57Fair
57Fair
57Fair
59Fair
59Fair
59Fair

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$34.44
Change on the day-1.85%
Market capitalisation$806M—
Shares traded on the day501.2K

Price & events

Other perspectives

Council score for Helen of Troy (HELE): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Neutral
Financial Safety Negative
Valuation Moderate
Growth Durability Neutral
Momentum Strong

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 19, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Weak
ROE Negative
Gross Margin Moderate

Read on: Nov 19, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 19, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Helen of Troy (HELE), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Helen of Troy Limited (HELE) is listed on NASDAQ. It employs 1,854 people. The market values it at $806M.

2 · Latest results

What do the latest results show for Helen of Troy (HELE)?

Short answer · as of

Against analyst estimates the company has EPS beat 1 of the last 4 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Aug 2025$432M-$309M-$13.44 (diluted)
Q3 FY2026$513M-$84M-$3.65 (diluted)
Q4 FY2026$470M-$56M-$2.41 (diluted)
Q1 FY2027$402M$36M$1.51 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Helen of Troy (HELE)?

Short answer

The MoonshotScore pillars rate positive momentum as strengths. What is holding it back is balance-sheet strain. The distress and quality screens read Altman Z 1.83 · Piotroski F 5. Trailing ratios: ROE -11.1% · ROA 2.8% · current ratio 1.65.

Data-derived red flags

  • Negative return on equity (-11.1%) — the business is not currently generating profit on shareholder capital.
  • Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
4 · What to check next?

What should you watch next at Helen of Troy (HELE)?

Short answer · as of

The stored analyst-target capture is expired, so a current target watchpoint is unavailable.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Helen of Troy compare with its peers?

Short answer

Helen of Troy's score ranks 9th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Inter Parfums, Inc. (IPAR) Same industry, near in market value$137.42 Nov 20, 2026$4.40B96 5-pillar Nov 18, 2026
Spectrum Brands Holdings, Inc. (SPB) Same industry, near in market value$80.65 Nov 20, 2026$1.86B87 5-pillar Nov 18, 2026
e.l.f. Beauty, Inc. (ELF) Same industry, near in market value$103.47 Nov 20, 2026$6.12B84 5-pillar Nov 18, 2026
AXIL Brands, Inc. (AXIL) Same industry, near in market value$4.27 Nov 20, 2026$29.1M84 5-pillar Nov 18, 2026
United-Guardian, Inc. (UG) Same industry, near in market value$7.35 Nov 20, 2026$33.8M83 5-pillar Nov 18, 2026
Acme United Corporation (ACU) Same industry, near in market value$66.17 Nov 20, 2026$263M76 5-pillar Nov 18, 2026
Solésence, Inc. (SLSN) Same industry, near in market value$1.41 Nov 20, 2026$99.6M64 5-pillar Nov 18, 2026
The Clorox Company (CLX) Named competitor$104.73 Nov 20, 2026$12.7B60 5-pillar Nov 18, 2026
Helen of Troy (HELE) — this page$34.44$806M59
Somnigroup International Inc (SGI) Same industry, near in market value$57.82 Nov 20, 2026$13.3B58 5-pillar Nov 18, 2026
Edgewell Personal Care Company (EPC) Same industry, near in market value$28.47 Nov 20, 2026$1.31B38 5-pillar Nov 18, 2026
Nu Skin Enterprises, Inc. (NUS) Same industry, near in market value$3.80 Nov 20, 2026$185M35 5-pillar Nov 18, 2026
The Beauty Health Company (SKIN) Same industry, near in market value$11.77 Nov 20, 2026$76.7M27 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
$26.00 – $28.00
Last captured analyst target (expired, captured Nov 18, 2026)
$27.00
Last captured median analyst target (expired, captured Nov 18, 2026)
$27.00

Historical target record · Captured · Capture expired; not a current watchpoint.

Insider activity

Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Oct 5, 2026

Transactions
18
Identified insiders
12
Purchases
0
Sales
0
Other transactions
18

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held HELE in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported HELE in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Investor Questions: HELE Stock

These answers are editorial: 1 of these 9 answers is drawn from the HELE research dossier (written May 7, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for HELE?

HELE carries the MoonshotScore stated above — the Fair band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is HELE a good stock to buy?

Stock Expert AI does not rate HELE buy, sell or hold. Helen of Troy Limited carries a MoonshotScore, in the Fair band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the HELE stock price today?

The last price recorded for Helen of Troy Limited (HELE), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the HELE price target?

The last analyst consensus price target we captured for Helen of Troy Limited (HELE), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

What does Helen of Troy Limited do?

Helen of Troy Limited is a global consumer products company that designs, develops, and markets a diverse range of products under a portfolio of well-known brands. The company operates through three segments: Home & Outdoor, Health & Wellness, and Beauty.

What are the key factors to evaluate for HELE?

Helen of Troy Limited (HELE) holds a MoonshotScore in the moderate range. Expanding its range of air purifiers, water filtration systems, and personal care devices can cater to this growing demand. Not financial advice.

How frequently does HELE data refresh on this page?

HELE's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven HELE's recent stock price performance?

Helen of Troy Limited (HELE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand portfolio with well-known brands like OXO, Hydro Flask, and PUR. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HELE overvalued or undervalued right now?

Helen of Troy Limited (HELE) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 7, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 14 figures on this page — 10 from Financial Modeling Prep (FMP), 3 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.